The CDSCO has approved a new indication for Wegovy (semaglutide injection 2.4 mg) for treatment of noncirrhotic metabolic ...
July 17 (Reuters) - Danish drugmaker Novo Nordisk said on Friday that India's drug regulator has approved its obesity drug ...
A study reveals dietary coaching aids weight loss equally in individuals with high and low genetic obesity risk, challenging ...
MEXICO: TANZANIA is pursuing a comprehensive strategy to tackle malnutrition while addressing the growing burden of ...
Novo Nordisk's Wegovy receives CDSCO approval as India's first GLP-1 treatment for fatty liver disease, addressing rising ...
Explore how GLP-1 medications impact skin, hair, and nails, emphasizing the importance of coordinated care for patients.
Researchers develop a new way of assessing a person’s risk of heart failure or death, by using AI during chest scans to measure the size of the pectoral muscle ...
Doctors are warning that popular GLP-1 medications used for diabetes and weight loss, including drugs such as Ozempic and ...
Doctors attribute rise in complicated pregnancies to delayed motherhood, obesity, diabetes and other pre-existing conditions; ...
Why do some people lose substantial weight with GLP-1-based medications while others see more modest results? A Mayo Clinic ...
A meta-analysis of 10 randomized controlled trials involving more than 23,000 participants, presented at the International ...
Body Mass Index (BMI) has long been the standard tool for determining whether a person falls into the underweight, healthy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results